Nuveen Asset Management Portfolio holdings
Nuveen Asset Management, founded in 1898 by John Nuveen and headquartered in Chicago, Illinois, is a leading global investment manager and subsidiary of TIAA, overseeing hundreds of billions in assets with a focus on fixed income, equities, and sustainable investing. Initially known for municipal bonds, Nuveen has expanded into a broad range of strategies, including mutual funds, ETFs, closed-end funds, and private capital solutions, serving institutional investors, financial advisors, and individuals. The firm emphasizes income-generating investments and ESG (environmental, social, governance) integration, leveraging its deep research capabilities and a century-long legacy in the bond market. With a strong presence in North America and growing international reach, Nuveen blends tradition with innovation to meet diverse client needs in the evolving investment landscape.
Top Buys
| 1 |
Kenvue
KVUE
|
+$503M |
| 2 |
Intel
INTC
|
+$390M |
| 3 |
Zoetis
ZTS
|
+$245M |
| 4 |
Philip Morris
PM
|
+$216M |
| 5 |
Honeywell
HON
|
+$198M |
Top Sells
| 1 |
PepsiCo
PEP
|
+$525M |
| 2 |
RTX Corp
RTX
|
+$357M |
| 3 |
Apple
AAPL
|
+$341M |
| 4 |
Union Pacific
UNP
|
+$292M |
| 5 |
Microsoft
MSFT
|
+$243M |
Sector Composition
| 1 | Technology | 26.55% |
| 2 | Healthcare | 12.07% |
| 3 | Financials | 11.17% |
| 4 | Consumer Discretionary | 10.62% |
| 5 | Industrials | 8.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2651
Definitive Healthcare
DH
$426M
| $738K | ﹤0.01% |
92,337
-312
| -0.3% | -$2.49K |
|
2652
HCI Group
HCI
$2.31B
| $737K | ﹤0.01% |
13,576
| – | – |
|
2653
Monte Rosa Therapeutics
GLUE
$400M
| $737K | ﹤0.01% |
153,843
+12,815
| +9% | +$61.4K |
|
2654
Sutro Biopharma
STRO
$75.6M
| $736K | ﹤0.01% |
212,145
-1,474
| -0.7% | -$5.12K |
|
|
GPMT
2655
Granite Point Mortgage Trust
GPMT
$140M
| $735K | ﹤0.01% |
150,647
-1,822
| -1% | -$8.89K |
|
2656
SAP
SAP
$295B
| $732K | ﹤0.01% |
5,662
+187
| +3% | +$24.2K |
|
2657
Summit Therapeutics
SMMT
$13.5B
| $729K | ﹤0.01% |
389,747
| – | – |
|
2658
Viemed Healthcare
VMD
$259M
| $728K | ﹤0.01% |
+108,112
| New | +$728K |
|
|
VTNR
2659
DELISTED
Vertex Energy, Inc
VTNR
| $727K | ﹤0.01% |
163,389
-3,793
| -2% | -$16.9K |
|
|
ENFN
2660
DELISTED
Enfusion, Inc.
ENFN
| $724K | ﹤0.01% |
80,713
+16,453
| +26% | +$148K |
|
2661
inTEST
INTT
$91.7M
| $724K | ﹤0.01% |
47,709
+33,249
| +230% | +$504K |
|
2662
Forum Energy Technologies
FET
$316M
| $720K | ﹤0.01% |
29,976
-13,665
| -31% | -$328K |
|
|
PINE
2663
Alpine Income Property Trust
PINE
$206M
| $719K | ﹤0.01% |
43,965
| – | – |
|
2664
Waterstone Financial
WSBF
$281M
| $719K | ﹤0.01% |
65,633
-6,261
| -9% | -$68.6K |
|
2665
Dakota Gold
DC
$503M
| $718K | ﹤0.01% |
278,455
-3,773
| -1% | -$9.73K |
|
2666
Eos Energy Enterprises
EOSE
$2.31B
| $716K | ﹤0.01% |
332,839
| – | – |
|
2667
Microvast
MVST
$1.05B
| $716K | ﹤0.01% |
378,599
-283,901
| -43% | -$537K |
|
2668
Bowman Consulting
BWMN
$733M
| $714K | ﹤0.01% |
25,461
| – | – |
|
2669
RLX Technology
RLX
$3.12B
| $713K | ﹤0.01% |
472,400
| – | – |
|
2670
West Bancorporation
WTBA
$344M
| $713K | ﹤0.01% |
43,734
-453
| -1% | -$7.39K |
|
2671
Cullinan Oncology
CGEM
$372M
| $711K | ﹤0.01% |
78,616
+1,305
| +2% | +$11.8K |
|
2672
Aviat Networks
AVNW
$301M
| $704K | ﹤0.01% |
22,574
| – | – |
|
2673
ProKidney
PROK
$354M
| $701K | ﹤0.01% |
153,160
-57,732
| -27% | -$264K |
|
|
LSEA
2674
DELISTED
Landsea Homes
LSEA
| $701K | ﹤0.01% |
78,010
+19,470
| +33% | +$175K |
|
2675
Riley Exploration Permian
REPX
$618M
| $699K | ﹤0.01% |
22,000
| – | – |
|